» Articles » PMID: 19741557

Management of Symptomatic Meesmann Dystrophy

Overview
Journal Optom Vis Sci
Date 2009 Sep 11
PMID 19741557
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Meesmann dystrophy is a non-progressive autosomal dominant corneal epithelial dystrophy characterized by intraepithelial cysts, which is likely to be caused by an intraepithelial metabolic abnormality. Cases may be asymptomatic or be associated with symptoms of irritation, lacrimation, and photophobia. Palliative treatment includes ocular lubricants, cycloplegia, and therapeutic contact lenses. In severe cases, management with epithelial debridement, phototherapeutic keratectomy, and lamellar keratoplasty has been advocated. Most recently, the genetic and molecular basis of Meesmann dystrophy have been explored, and mutations in the genes encoding corneal epithelial keratins have been reported. This report describes a case of Meesmann dystrophy with unusually severe symptoms and punctate epithelial keratopathy managed with a therapeutic contact lens.

Citing Articles

Femtosecond laser-assisted laser in situ keratomileusis for the correction of high myopia in Meesmann corneal dystrophy: a case report.

Hashemi H, Aghamirsalim M, Mehravaran S, Asgari S Arq Bras Oftalmol. 2022; 86(2):175-177.

PMID: 35170649 PMC: 11892480. DOI: 10.5935/0004-2749.20230003.


Corneal dystrophies.

Soh Y, Kocaba V, Weiss J, Jurkunas U, Kinoshita S, Aldave A Nat Rev Dis Primers. 2020; 6(1):46.

PMID: 32528047 DOI: 10.1038/s41572-020-0178-9.


Identification of presumed pathogenic KRT3 and KRT12 gene mutations associated with Meesmann corneal dystrophy.

Chen J, Lin B, Gee K, Gee J, Chung D, Frausto R Mol Vis. 2016; 21:1378-86.

PMID: 26788030 PMC: 4704769.